Heaptalk, Jakarta — Virtus Medical Holdings Limited completed of new capital raising for an undisclosed amount. The funding round was led by Shanghai Healthcare Capital (SHC), along with Mitsui & Co., Ltd. (Mitsui), and Shanghai MediTrust Health Technology Co. Ltd. (MediTrust).
This strategic investment plays a pivotal role with Virtus Medical joining hands with SHC, Mitsui, MediTrust and a group of leading institutional investors including Cenova Capital, Government of Singapore Investment Corporation (GIC) and Samena Capital to focus on utilizing big data and insights, leveraging technology advancement to improve patient care, elevating the healthcare value chain, and driving quality healthcare and innovation to the market.
Since 2018, Virtus Medical is committed to driving adoption of advancements in medical technologies and delivering comprehensive care to address the evolving healthcare needs of the community. The Group has consistently demonstrated its capabilities and expertise in delivering high-quality healthcare services. The Group boasts a team of over 60 specialists, along with more than 40 general practitioners and allied healthcare professionals.
Virtus Medical plans to utilize this funding and leverage the new investors’ global operations, collaborating the shared knowledge of innovation and patient care to strengthen its operation and pursue strategic acquisitions that complement its existing capabilities. The Group will also build on existing partnerships with leading insurance and corporate institutions to harness the development of new healthcare services and solutions for the customers in the territory.
The funding secured in this round will empower Virtus Medical to fuel its growth strategies, expand its network, and enhance its range of medical services. By leveraging the expertise and support of its investors, Virtus Medical is committed to driving advancements in medical technologies and delivering comprehensive care to address the evolving healthcare needs of the community.
Dr. Manson Fok, Chairman of Virtus Medical expressed, “We are privileged to have attracted new capital and partners, and the completion of this funding round is a significant milestone as we solidify our leadership position in quality private healthcare. The combined strategic strengths among our existing and new shareholders open to us an unprecedented window of opportunity to continue the journey in delivering best in class healthcare services and onboarding innovations.”
Mr. Samuel Poon, CEO of Virtus Medical stated, “We are excited about the opportunities that lie ahead and the potential to further enhance our offerings through cross-border healthcare development. The additional capital allows us to invest strategically, so we can deliver on our mission to develop an evidence-based healthcare practice with a patient-centred culture, providing personalised total health solutions through integrated approaches. Moving forward, our medical team will collaborate closely with our financial backers to deliver even better patient services.”
Ms. Leng Wei Qing, Chairman of Shanghai Industrial Investment (Holdings) Co., Ltd said, “We see an untapped opportunity in creating an integrated value chain within the Greater Bay Area’s healthcare ecosystem. Our strategic partnership with Virtus Medical elevates our ties between Shanghai and Hong Kong, and will strengthen the healthcare services in bridging the gap that’s needed to create this value chain. Our partnership will also see us utilizing the latest technology and innovation to enable us to add more value to product offerings for the insurance industry and to our corporate partners. I am most delighted to work together with Dr. Fok and the Virtus Medical team to deliver on this vision together.”
Mr. Takeshi Saito, General Manager of Healthcare Network Business Division at Mitsui & Co., Ltd. said, “Our partnership with Virtus Medical will create collaboration opportunities with our presence globally. We are very excited to share and exchange our knowledge in business development, operational improvement, digital transformation and patient experience, to reach new heights together. We will also look at continuous growth in assets and introduction of new medical innovative technology to add value to the team at Virtus Medical.”
Mr. Seth Zhang, Founder and CEO of Shanghai MediTrust Health Technology Co. Ltd. said, “We see opportunities to enhance healthcare services. This collaboration will create great synergy with our partners in insurance sector and corporates to create value add in providing personalized healthcare for the new generation.”
